Skip to content

How Do You Know if Xiidra Is Working? Recognizing Signs of Dry Eye Relief

4 min read

According to clinical trials, some patients using Xiidra report symptom relief in as little as two weeks, but it can take up to 12 weeks to feel the full therapeutic effect. Knowing how to monitor your progress is key to understanding if the medication is working for your dry eye disease, which requires regular and consistent use.

Quick Summary

This guide details the subjective signs and objective indicators that suggest Xiidra is effectively treating dry eye disease. It explains the typical timeline for improvement and when to consult a doctor if satisfactory results are not apparent.

Key Points

  • Initial Relief (2-4 weeks): Many patients notice some symptomatic improvement, such as less dryness and irritation, within a few weeks of starting Xiidra.

  • Full Therapeutic Effect (6-12 weeks): Maximum benefit from Xiidra's anti-inflammatory action typically occurs between six and twelve weeks of consistent use.

  • Subjective Symptoms to Monitor: Track a decrease in burning, stinging, grittiness, redness, and fluctuations in vision as key indicators of progress.

  • Objective Signs for Your Doctor: Your eye care professional can measure objective improvements like reduced corneal staining, which is a sign of a healthier ocular surface.

  • Side Effects May Subside: Common initial side effects like eye irritation or an unusual taste sensation may decrease over time as the medication takes effect.

  • Patience is Key: Due to its anti-inflammatory mechanism, Xiidra is not an instant-relief medication, and it is important to complete the prescribed course before evaluating its full effectiveness.

  • Consult a Professional: If no noticeable improvement occurs after 12 weeks, consult your eye doctor to discuss next steps, which may include combining therapies or exploring alternative treatments.

In This Article

Xiidra (lifitegrast) is a prescription eye drop used to treat the signs and symptoms of chronic dry eye disease. Unlike artificial tears, which only provide temporary moisture, Xiidra targets the inflammation that often drives the condition. However, because it works by treating the underlying inflammation, it can take time to see and feel the full benefits. Patients often wonder what signs to look for to know if their treatment is effective. Recognizing the signs of improvement requires patience and consistent tracking of both your own subjective experience and the objective findings of your eye doctor.

The Xiidra Efficacy Timeline

The onset of Xiidra's effectiveness is a gradual process. It is important to manage expectations and understand that relief is not instant, as it is with lubricating drops.

  • Initial effects (2-4 weeks): In some clinical studies, patients began noticing improvement in dry eye symptoms around two weeks. This initial relief may be subtle and could manifest as a slight reduction in eye dryness or discomfort. Consistency with the twice-daily dosage is crucial during this period.
  • Continued improvement (6-12 weeks): The full therapeutic effect of Xiidra may take six to twelve weeks to become noticeable. The anti-inflammatory action builds over time, leading to more significant and lasting relief. Improvements were observed at 6 and 12 weeks in all four major clinical studies.
  • Long-term results: For many, Xiidra is a long-term treatment. Its continued, regular use helps maintain symptom relief by consistently targeting the source of inflammation. Some patients have been shown to maintain their dry eye improvement over a year of consistent use.

Subjective Signs of Improvement (What You Will Feel)

The most straightforward way to know if Xiidra is working is by paying attention to changes in your symptoms. Keeping a journal can help track these improvements over time.

Here are some of the subjective signs of dry eye relief you may experience:

  • Less eye dryness: A reduction in the overall feeling of dryness throughout the day.
  • Reduced burning or stinging: The frequent sensation of burning or stinging decreases, especially in environments that previously triggered symptoms, such as windy conditions or air-conditioned rooms.
  • Decreased grittiness: The sensation of having sand or a foreign body in your eye subsides.
  • Less redness: The chronic redness in your eyes, a common sign of inflammation, begins to fade.
  • Clearer vision: Dry eye can cause blurry or fluctuating vision, which should improve as the ocular surface becomes healthier.
  • Increased comfort with contact lenses: For contact lens wearers, Xiidra has been shown to improve end-of-day dryness and discomfort, potentially leading to longer comfortable wear times.
  • Fewer instances of watering: While it might seem counterintuitive, dry eye can cause reflex tearing. As the underlying inflammation is treated, this excessive tearing may decrease.

Objective Signs of Improvement (What Your Doctor Will See)

An eye doctor can assess the effectiveness of Xiidra by performing objective tests during your follow-up appointments. These clinical signs are often the best indicators of success, especially if your symptomatic relief is still building.

  • Reduced corneal staining: This test uses a special dye to highlight damage on the surface of the eye. A reduction in staining indicates healing of the corneal surface.
  • Increased tear production: Your doctor may perform a Schirmer's test, which measures tear volume. An increase in natural tear production can indicate the medication is working.
  • Improved tear film stability: Tests can evaluate the time it takes for your tear film to break up. A more stable tear film is a sign of improved ocular health.

Comparison: Xiidra vs. Other Dry Eye Medications

To understand Xiidra's role in dry eye treatment, it is helpful to compare its pharmacology and timeline with other options, such as Restasis (cyclosporine), another prescription anti-inflammatory drop.

Feature Xiidra (Lifitegrast) Restasis (Cyclosporine)
Mechanism of Action Blocks LFA-1 protein, reducing inflammation caused by activated T-cells. Suppresses T-cell activation and proliferation to decrease inflammation.
Time to Symptom Relief Often begins in as little as 2-4 weeks, with full effect by 6-12 weeks. Can take significantly longer, sometimes 3-6 months or more, to notice significant improvement.
Common Side Effects Eye irritation, discomfort, blurred vision, and an unusual taste sensation. Ocular burning or stinging upon instillation.
Treatment Type Targets a specific inflammatory pathway. More broadly suppresses the underlying immune response causing inflammation.

What to Do If You Don't See Improvement

If you have been using Xiidra consistently for 12 weeks and have not experienced significant relief, it is essential to contact your eye care provider. Lack of improvement does not mean that treatment for dry eye disease is impossible, but rather that a different approach may be necessary.

Your doctor may consider the following steps:

  • Adjunctive therapy: Combining Xiidra with other treatments, like artificial tears or a short course of steroid eye drops, may be recommended.
  • Switching medication: Another prescription eye drop, like Restasis or Cequa, could be a better fit for your specific condition.
  • Exploring other causes: Dry eye can stem from various causes, including meibomian gland dysfunction (MGD), which may require specialized treatments like LipiFlow to unclog oil glands.
  • Addressing lifestyle factors: Your doctor may suggest lifestyle changes to minimize aggravating factors like environmental irritants or extensive screen time.

Conclusion

Knowing how to tell if Xiidra is working involves paying close attention to both your symptomatic experience and your doctor's clinical findings over several months. Since it addresses the root cause of inflammation, patience is a key component of the treatment plan. Initial relief may begin within a few weeks, but the maximum benefit is typically observed after 6 to 12 weeks of consistent, twice-daily use. By partnering with your eye care professional and monitoring your progress, you can effectively determine if Xiidra is the right medication for your dry eye disease and explore other options if needed.

For more information on dry eye treatments and symptoms, consult your healthcare provider or visit the National Eye Institute.

Frequently Asked Questions

Some patients start feeling symptom relief within two weeks of consistent, twice-daily use. However, the full anti-inflammatory effect can take up to 12 weeks to manifest, so it is important to be patient and continue the medication as prescribed.

If Xiidra is working, you may notice significant improvements in end-of-day dryness and discomfort, potentially increasing your comfortable wearing time. Studies have shown this can occur in as little as two weeks, with further improvements over time.

A metallic or unusual taste in your mouth is a known side effect of Xiidra that occurs as the medication drains through your tear ducts into your nasal passages. It does not indicate that the medication is failing and may even become less noticeable over time as your symptoms improve.

Mild eye irritation or stinging upon instillation is a common side effect, especially during the initial weeks of treatment. This is not a sign of failure and often decreases as the medication starts to improve your underlying dry eye condition. If it is severe or persistent, speak with your doctor.

If you see no significant improvement after 12 weeks of consistent use, it's time to consult your eye doctor again. They may consider a combination therapy, switching to a different medication like Restasis, or investigating other potential causes of your dry eye.

Yes. While you feel the symptomatic changes, your doctor can see objective proof through an eye exam. They use tests like fluorescein staining to observe a reduction in corneal damage and can also measure improvements in tear film stability.

Xiidra treats the underlying inflammation associated with dry eye disease. Its active ingredient, lifitegrast, works by blocking a specific protein (LFA-1) on inflammatory cells, which helps the eye's natural tear film become more stable over time.

References

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10

Medical Disclaimer

This content is for informational purposes only and should not replace professional medical advice.